eMedicine Specialties > Emergency Medicine > Ophthalmology

Globe Rupture: Treatment & Medication

Author: Joe Robson, MD, Consulting Staff, Emergency Service Partners, Department of Emergency Medicine, Palestine Regional Medical Center, Guadalupe Regional Medical Center, St Joseph Medical Center, Cedar Park Regional Medical Center
Coauthor(s): Amy J Behrman, MD, Associate Professor, Department of Emergency Medicine, Director, Division of Occupational Medicine, University of Pennsylvania School of Medicine; Stephanie Abbuhl, MD, Vice Chair, Associate Professor, Department of Emergency Medicine, University of Pennsylvania School of Medicine; Attending Physician in Emergency Services, Hospital of the University of Pennsylvania
Contributor Information and Disclosures

Updated: Jul 16, 2009

Treatment

Prehospital Care

  • A suspected or obvious ruptured globe should be protected from any pressure or inadvertent contact with a rigid shield during transport.
  • Impaled foreign bodies should be left undisturbed.
  • Eye patches are contraindicated.

Emergency Department Care

  • Avoid all pressure on or around the injured eye to prevent extrusion of intraocular contents. Continue to protect the eye with a rigid shield. If a shield is not available, the bottom of a Styrofoam cup works well.
  • Administer antiemetics (eg, promethazine [Phenergan], prochlorperazine [Compazine]) to prevent Valsalva maneuvers.
  • Administer analgesics as indicated.
  • Administer prophylactic antibiotics, ideally within 6 hours of the injury, to prevent endophthalmitis. This potentially devastating complication occurs in about 5% of penetrating trauma cases and in as many as 10% of trauma cases from a foreign body. Skin organisms, such as Streptococcus species, Staphylococcus aureus, and Staphylococcus epidermidis are most frequently involved. Attention should be given to species-specific pathogens if injury is due to bites (ie, dysgonic fermenter type 2 [DF2] and Eikenella for dog bites; Pasteurella multocida for cat bites) or if organic material is likely to have been introduced (ie, gram-negative organisms or fungi in a farming injury).
  • Document tetanus immune status and update as indicated.
  • Ascertain what time was the last meal. The patient should be kept NPO.
  • Consult an ophthalmologist, and admit the patient to the hospital on bedrest with bathroom privileges.
  • Surgical repair should be expedited. If repair is impossible, enucleation usually is necessary, either initially or within the first 7-14 days after the trauma.
  • Ocular steroids have no role in the acute setting of a ruptured globe.

Consultations

  • Ophthalmologist
    • Consult an ophthalmologist immediately.
    • Avoid any further manipulation of the injured eye while protection with a rigid shield is maintained, pending evaluation by an ophthalmologist.

Medication

The goal of pharmacotherapy is to prevent infections and pathophysiologic complications.

Antibiotics

Prophylactic systemic antibiotics are indicated in all cases of globe rupture. The risk of posttraumatic endophthalmitis is greatest when a penetrating injury exists, particularly with a retained intraorbital foreign body. Skin flora are the most common organisms, but contamination with soil, farm or animal flora, human saliva, or nonsterile water may introduce gram-negative organisms, anaerobes, and fungi. A complete list of antibiotics and their spectrum of activity is beyond the scope of this article. An example regimen is listed:

For adults, give cefazolin 1 g IV q8h plus ciprofloxacin 400 mg IV q12h. Newer fluoroquinolones, gatifloxacin and moxifloxacin, may have better vitreous penetration and anaerobic activity.

For children <12 years, give cefazolin 25-50 mg/kg/d IV divided tid plus gentamicin 2 mg/kg IV q8h.

If surgery must be delayed for any reason or if foreign body and/or organic contamination are considered likely, antibiotics with better penetration of the vitreous should be used prophylactically.

The list below provides examples of potential antibiotic choices and is not an exhaustive discussion. The ultimate choice of antibiotics is based on the individual characteristics of the injury and the patient, the determination of the degree of risk for infection and the likely organisms involved, and a specific drug's intraocular penetration characteristics.


Cefazolin (Ancef, Kefzol, Zolicef)

First-generation semisynthetic cephalosporin that by binding to 1 or more penicillin-binding proteins arrests bacterial cell wall synthesis and inhibits bacterial replication. Poor capacity to cross blood-brain barrier. Primarily active against skin flora, including S aureus. Typically used alone for skin and skin-structure coverage. Regimens for IV and IM dosing are similar.

Adult

1 g IV q8h

Pediatric

25-50 mg/kg/d IV divided tid

Probenecid prolongs effect of cefazolin; coadministration with aminoglycosides may increase renal toxicity; may yield false-positive urine-dip test result for glucose

Pregnancy

B - Fetal risk not confirmed in studies in humans but has been shown in some studies in animals

Precautions

Adjust dose in renal impairment; superinfections and promotion of nonsusceptible organisms may occur with prolonged use or repeated therapy


Ciprofloxacin (Cipro)

Provides excellent coverage against staphylococcal organisms and Pseudomonas, but it is not a good antibiotic for streptococci or anaerobes. Has excellent penetration of the eye in IV form. Anaerobic coverage can be achieved with addition of clindamycin, which also covers streptococci, except for enterococci.

Adult

400 mg IV q12h

Pediatric

<18 years: Not recommended
>18 years: Administer as in adults

Antacids, iron salts, and zinc salts may reduce serum levels; administer antacids 2-4 h before or after taking fluoroquinolones; cimetidine may interfere with metabolism of fluoroquinolones; ciprofloxacin reduces therapeutic effects of phenytoin; probenecid may increase ciprofloxacin serum concentrations; may increase toxicity of theophylline, caffeine, cyclosporine, and digoxin (monitor digoxin levels); may increase effects of anticoagulants (monitor PT)

Pregnancy

C - Fetal risk revealed in studies in animals but not established or not studied in humans; may use if benefits outweigh risk to fetus

Precautions

In prolonged therapy, perform periodic evaluations of organ system functions (eg, renal, hepatic, hematopoietic); adjust dose in renal function impairment; superinfections may occur with prolonged or repeated antibiotic therapy


Tobramycin (Nebcin)

Aminoglycoside used as an alternative for children allergic to penicillin or for breastfeeding or pregnant women. Add clindamycin if anaerobic contamination is likely.

Adult

1.5-2 mg/kg IV loading dose; followed by 1.5-1.7 mg/kg IV q8h maintenance dose

Pediatric

4-5 mg/kg/d IV divided q8h

Increases effects of neuromuscular blockers and potentiates effect of extended-spectrum penicillins; concurrent administration with amphotericin B, cephalosporins, and loop diuretics increases risk of nephrotoxicity

Pregnancy

B - Fetal risk not confirmed in studies in humans but has been shown in some studies in animals

Precautions

Caution in renal impairment, in preexisting auditory or vestibular impairment, and in patients with neuromuscular disorders; aminoglycosides are associated with nephrotoxicity and ototoxicity


Clindamycin (Cleocin)

Often added to ciprofloxacin or tobramycin for coverage of anaerobes and streptococci.

Adult

600-900 mg IV q8h

Pediatric

20-40 mg/kg/d IV divided q6-8h

Increases duration of neuromuscular blockade, induced by tubocurarine and pancuronium; erythromycin may antagonize effects of clindamycin; antidiarrheals may delay absorption of clindamycin

Documented hypersensitivity; regional enteritis; ulcerative colitis; hepatic impairment; antibiotic-associated colitis

Pregnancy

B - Fetal risk not confirmed in studies in humans but has been shown in some studies in animals

Precautions

Adjust dose in severe hepatic dysfunction; no adjustment necessary in renal insufficiency; associated with severe and possibly fatal colitis


Imipenem-cilastatin (Primaxin)

A penicillin-type antibiotic with broad coverage of gram-positive, gram-negative (including Pseudomonas), and anaerobic infections. Imipenem penetrates the aqueous and vitreous humor in high concentrations even without the presence of active inflammation.

Adult

1 g IV q6h

Pediatric

<12 years: Do not administer
>12 years: 12 mg/kg IV q6h; not to exceed 4 g/d

Coadministration with cyclosporine may increase CNS side effects of both agents; coadministration with ganciclovir may result in generalized seizures

Pregnancy

C - Fetal risk revealed in studies in animals but not established or not studied in humans; may use if benefits outweigh risk to fetus

Precautions

Adjust dose in renal insufficiency


Gentamicin (Garamycin, Jenamicin)

Aminoglycoside antibiotic for gram-negative coverage bacteria including Pseudomonas species. Synergistic with beta-lactamase against enterococci. Interferes with bacterial protein synthesis by binding to 30S and 50S ribosomal subunits.
Dosing regimens are numerous and are adjusted based on CrCl and changes in volume of distribution, as well as body space into which agent needs to distribute. Dose of gentamicin may be given IV/IM. Each regimen must be followed by at least trough level drawn on third or fourth dose, 0.5 h before dosing; may draw peak level 0.5 h after 30-min infusion.

Adult

Serious infections and normal renal function: 3 mg/kg/dose IV q8h
Loading dose and maintenance dose: 1-2.5 mg/kg IV and 1-1.5 mg/kg IV, respectively, q8h
Extended-dosing regimen for life-threatening infections: 5 mg/kg/d IV/IM q6-8h
Follow each regimen by at least a trough level drawn on third or fourth dose (0.5 h before dosing); may draw a peak level 0.5 h after 30-min infusion

Pediatric

2 mg/kg IV q8h

Coadministration with other aminoglycosides, cephalosporins, penicillins, and amphotericin B may increase nephrotoxicity; because aminoglycosides enhance effects of neuromuscular blocking agents, prolonged respiratory depression may occur; coadministration with loop diuretics may increase auditory toxicity of aminoglycosides; possible irreversible hearing loss of varying degrees may occur (monitor regularly)

Documented hypersensitivity; non–dialysis-dependent renal insufficiency

Pregnancy

D - Fetal risk shown in humans; use only if benefits outweigh risk to fetus

Precautions

Narrow therapeutic index (not intended for long-term therapy); caution in renal failure (not on dialysis), myasthenia gravis, hypocalcemia, and conditions that depress neuromuscular transmission; adjust dose in renal impairment


Vancomycin

May be used as an alternative to cefazolin for adults allergic to penicillin. Provides excellent gram-positive coverage, including Bacillus. To avoid toxicity, current recommendation is to assay vancomycin trough levels after third dose drawn 0.5 h prior to next dose. Use creatinine clearance to adjust dose in patients with renal impairment.

Adult

1 g IV q12h

Pediatric

40 mg/kg/d IV

Erythema, histaminelike flushing, and anaphylactic reactions may occur when administered with anesthetic agents; taken concurrently with aminoglycosides, risk of nephrotoxicity may increase above that with aminoglycoside monotherapy; effects in neuromuscular blockade may be enhanced when coadministered with nondepolarizing muscle relaxants

Pregnancy

C - Fetal risk revealed in studies in animals but not established or not studied in humans; may use if benefits outweigh risk to fetus

Precautions

Caution in renal failure, neutropenia; red man syndrome is caused by too rapid IV infusion (dose given over a few min) but rarely happens when dose given IV over 2-h administration or as PO or IP administration; red man syndrome is not an allergic reaction

More on Globe Rupture

Overview: Globe Rupture
Differential Diagnoses & Workup: Globe Rupture
Treatment & Medication: Globe Rupture
Follow-up: Globe Rupture
Multimedia: Globe Rupture
References

References

  1. Rodriguez JO, Lavina AM, Agarwal A. Prevention and treatment of common eye injuries in sports. Am Fam Physician. Apr 1 2003;67(7):1481-8. [Medline].

  2. Listman DA. Paintball injuries in children: more than meets the eye. Pediatrics. Jan 2004;113(1 Pt 1):e15-8. [Medline].

  3. Lee CH, Lee L, Kao LY, Lin KK, Yang ML. Prognostic indicators of open globe injuries in children. Am J Emerg Med. Jun 2009;27(5):530-5. [Medline].

  4. [Best Evidence] Unver YB, Kapran Z, Acar N, Altan T. Ocular trauma score in open-globe injuries. J Trauma. Apr 2009;66(4):1030-2. [Medline].

  5. Brunette DD. Ophthalmology. In: Rosen's Emergency Medicine. Vol 2. 2002:908-927.

  6. Catalano R. Ocular Emergencies. Philadelphia: WB Saunders;1992.

  7. Friedberg MA, Rapuano CJ. Office and Emergency Room Diagnosis and Treatment of Eye Disease. Philadelphia, Pa: JB Lippincott; 1990.

  8. Harlan JB, Pieramici DJ. Evaluation of patients with ocular trauma. Ophthalmol Clin North Am. Jun 2002;15(2):153-61. [Medline].

  9. Khaw PT, Shah P, Elkington AR. Injury to the eye. BMJ. Jan 3 2004;328(7430):36-8. [Medline].

  10. Kunimoto DY, Kanitar KD, Maker MS. The Wills Eye Manual. 4th ed. 2004.

  11. Linden JA, Renner GS, Scott. Trauma to the Globe. In: Emergency Medical Clinics of North America: Emergency Treatment of the Eye. Philadelphia: WB Saunders;1995.

  12. Mader TH, Carroll RD, Slade CS, George RK, Ritchey JP, Neville SP. Ocular war injuries of the Iraqi Insurgency,January-September 2004. Ophthalmology. Jan 2006;113(1):97-104. [Medline].

  13. Nelson LB. Injuries to the eye. In: Nelson Textbook of Pediatrics. Philadelphia, Pa: WB Saunders; 1996.

  14. Poon A, McCluskey PJ, Hill DA. Eye injuries in patients with major trauma. J Trauma. Mar 1999;46(3):494-9. [Medline].

  15. Sanford JP, Eliopoulos GM, Moellering RC. The Sanford Guide to Antimicrobial Therapy. Antimicrobial Therapy Inc; 2005.

  16. Vachon CA, Warner DO, Bacon DR. Succinylcholine and the open globe. Tracing the teaching. Anesthesiology. Jul 2003;99(1):220-3. [Medline].

Further Reading

Keywords

globe rupture, ocular trauma, vision loss, scleral rupture, open-globe injuries, open globe injuries, penetrating orbital traumas, blunt orbital traumas, eye injuries, penetrating eye injury, perforating eye injuries, foreign body in the eye

Contributor Information and Disclosures

Author

Joe Robson, MD, Consulting Staff, Emergency Service Partners, Department of Emergency Medicine, Palestine Regional Medical Center, Guadalupe Regional Medical Center, St Joseph Medical Center, Cedar Park Regional Medical Center
Joe Robson, MD is a member of the following medical societies: American Medical Association, Emergency Medicine Residents Association, and Society for Academic Emergency Medicine
Disclosure: Nothing to disclose.

Coauthor(s)

Amy J Behrman, MD, Associate Professor, Department of Emergency Medicine, Director, Division of Occupational Medicine, University of Pennsylvania School of Medicine
Amy J Behrman, MD is a member of the following medical societies: American College of Occupational and Environmental Medicine
Disclosure: Nothing to disclose.

Stephanie Abbuhl, MD, Vice Chair, Associate Professor, Department of Emergency Medicine, University of Pennsylvania School of Medicine; Attending Physician in Emergency Services, Hospital of the University of Pennsylvania
Stephanie Abbuhl, MD is a member of the following medical societies: Alpha Omega Alpha, American College of Emergency Physicians, Phi Beta Kappa, and Society for Academic Emergency Medicine
Disclosure: Nothing to disclose.

Medical Editor

Edward A Michelson, MD, Program Director, Associate Professor, Department of Emergency Medicine, University Hospital Health Systems in Cleveland
Edward A Michelson, MD is a member of the following medical societies: American College of Emergency Physicians, National Association of EMS Physicians, and Society for Academic Emergency Medicine
Disclosure: Nothing to disclose.

Pharmacy Editor

Francisco Talavera, PharmD, PhD, Senior Pharmacy Editor, eMedicine
Disclosure: eMedicine Salary Employment

Managing Editor

Douglas Lavenburg, MD, Clinical Professor, Department of Emergency Medicine, Christiana Care Health Systems
Douglas Lavenburg, MD is a member of the following medical societies: American Society of Cataract and Refractive Surgery
Disclosure: Nothing to disclose.

CME Editor

John D Halamka, MD, MS, Associate Professor of Medicine, Harvard Medical School, Beth Israel Deaconess Medical Center; Chief Information Officer, CareGroup Healthcare System and Harvard Medical School; Attending Physician, Division of Emergency Medicine, Beth Israel Deaconess Medical Center
John D Halamka, MD, MS is a member of the following medical societies: American College of Emergency Physicians, American Medical Informatics Association, Phi Beta Kappa, and Society for Academic Emergency Medicine
Disclosure: Nothing to disclose.

Chief Editor

Steven C Dronen, MD, FAAEM, Director of Emergency Services, Director of Chest Pain Center, Department of Emergency Medicine, Ft Sanders Sevier Medical Center
Steven C Dronen, MD, FAAEM is a member of the following medical societies: American Academy of Emergency Medicine and Society for Academic Emergency Medicine
Disclosure: Nothing to disclose.

 
 
HONcode

We subscribe to the
HONcode principles of the
Health On the Net Foundation

All material on this website is protected by copyright, Copyright© 1994- by Medscape.
This website also contains material copyrighted by 3rd parties.

DISCLAIMER: The content of this Website is not influenced by sponsors. The site is designed primarily for use by qualified physicians and other medical professionals. The information contained herein should NOT be used as a substitute for the advice of an appropriately qualified and licensed physician or other health care provider. The information provided here is for educational and informational purposes only. In no way should it be considered as offering medical advice. Please check with a physician if you suspect you are ill.